SPP1 and pulmonary fibrosis: CVT-6883 alleviated pulmonary inflammation and expression of pro-fibrotic factors, TGF-β1 and osteopontin (OPN), leading to diminished pulmonary fibrosis in a model of bleomycin-induced pulmonary injury [49].